In the high-stakes world of pharmaceutical innovation, securing a patent is only half the battle. The real challenge begins when patent challengers—be it generic manufacturers or patent trolls—launch a PTAB (Patent Trial and Appeal Board) challenge, th…

Breaking into the Russian Pharmaceutical Market: Opportunities and Challenges in a Changing Landscape
In an era where global pharmaceutical companies are constantly seeking new markets to fuel growth, Russia emerges as both a promising frontier and a c…

In the high-stakes world of pharmaceutical innovation, the battle over patents isn’t just a legal skirmish—it’s a defining moment that can shape the future of healthcare access and corporate strategy. Recently, a landmark case unfolded between Vifor Fr…

In the rapidly evolving landscape of pharmaceutical innovation, the race to develop groundbreaking therapies is more competitive—and complex—than ever before. As the industry pushes the boundaries of science, one challenge remains persistent: how to ef…

In the rapidly evolving landscape of global pharmaceuticals, the journey from innovation to accessible medicine is fraught with complexities—particularly when it comes to developing complex generic products for emerging markets. As patent protections e…

In the fiercely competitive world of pharmaceuticals, timing isn’t just everything—it’s the only thing. As the race to bring generic drugs to market accelerates, companies are faced with a critical question: How can they optimize their strategies to wi…

In the relentless pursuit of innovation, the pharmaceutical industry has long navigated a complex landscape of patents, exclusivities, and regulatory frameworks. But a recent deep dive into four decades of U.S. patent extension policies reveals a nuanc…